Outpatient vagus nerve stimulation surgery in patients with drug-resistant epilepsy with severe intellectual disability.


Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
05 2021
Historique:
received: 02 02 2021
revised: 03 03 2021
accepted: 05 03 2021
pubmed: 27 3 2021
medline: 20 5 2021
entrez: 26 3 2021
Statut: ppublish

Résumé

Vagus nerve stimulation (VNS) implantation is increasingly proposed in outpatient procedure. Some epilepsy syndromes are associated with severe neurodevelopmental disabilities (intellectual disability, autism) and often motor or sensory handicaps, making ambulatory surgery more complex. We prospectively assessed the feasibility and safety of outpatient VNS implantation in 26 adult patients with drug-resistant epilepsy with severe intellectual disability between December 2017 and October 2020. The male-to-female ratio was 0.9 and the mean age on surgery day was 23.1 years. Seventeen patients (65.4%) suffered from epileptic encephalopathy, 7 (26.9%) from cryptogenic or genetic generalized epilepsy, and 2 (7.7%) from severe multifocal epilepsy. Postoperatively, all patients were discharged the day of surgery. No patient was admitted to a hospital or have consulted within one month due to postoperative complications. There was no surgery-related complication during patients' follow-up. Our study highlights the safety and feasibility of VNS surgery in an outpatient setting for patients with severe intellectual disability. We report detailed protocol and preoperative checklist to optimize outpatient VNS surgery in these not able-bodied patients. Severe disabilities or epilepsy-associated handicaps should not be an exclusion criterion when considering ambulatory VNS implantation.

Identifiants

pubmed: 33770612
pii: S1525-5050(21)00165-7
doi: 10.1016/j.yebeh.2021.107931
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107931

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Dr. Bertrand Mathon has received support from Livanova. The remaining authors have no conflicts of interest.

Auteurs

Insafe Mezjan (I)

APHP, Department of Neurosurgery, Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France.

Isabelle Gourfinkel-An (I)

APHP, Department of Neurology, Epileptology Unit, Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France; APHP, Reference Center for Rare Epilepsies, Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France.

Vincent Degos (V)

APHP, Department of Anesthesia, Critical Care and Peri-Operative Medicine, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France; Clinical Research Group ARPE, Sorbonne University, Paris, France; INSERM UMR 1141, PROTECT, Paris, France.

Stéphane Clemenceau (S)

APHP, Department of Neurosurgery, Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France.

Vincent Navarro (V)

APHP, Department of Neurology, Epileptology Unit, Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France; APHP, Reference Center for Rare Epilepsies, Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France; Paris Brain Institute, INSERM, CNRS, Sorbonne University, UMR S 1127, Paris Brain Institute, ICM, F-75013 Paris, France.

Véronique Masson (V)

APHP, Department of Neurology, Epileptology Unit, Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France.

Alexandre Carpentier (A)

APHP, Department of Neurosurgery, Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France; Paris Brain Institute, INSERM, CNRS, Sorbonne University, UMR S 1127, Paris Brain Institute, ICM, F-75013 Paris, France.

Bertrand Mathon (B)

APHP, Department of Neurosurgery, Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France; Paris Brain Institute, INSERM, CNRS, Sorbonne University, UMR S 1127, Paris Brain Institute, ICM, F-75013 Paris, France. Electronic address: bertrand.mathon@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH